Literatur
Bujold A, Massey Ca, Kim JJ et al (2013) Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol 31:1631–1639
Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716
Guckenberger M, Allgauer M, Appold S et al (2013) Safety and efficacy of stereotactic body radiotherapy for stage i non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8(8):1050–1058
Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967
Moser G (2013) Bestallungen (Approbationen) jüdischer Ärzte erlöschen am 30. September 1938“ – Vor 75 Jahren entzog der NS-Gesetzgeber Ärztinnen und Ärzten die staatliche Berufszulassung. Fortschr Röntgenstr 185(10):930–935
Moser G (2014) Radiologie in der NS-Zeit – Teil 1 bis Teil 4. Fortschr Röntgenstr 186(1):17–21, 186(2):116–119, 186(3):212–217 und 186(4):329–333
Onishi H, Shirato H, Nagata Y et al (2011) Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81(5):1352–1358
Ott OJ, Jeremias C, Gaipl US et al (2014) Radiotherapy for benign calcaneodynia: long-term results of the Erlangen Dose Optimization (EDO) trial. Strahlenther Onkol 190(7):671–675
Ott OJ, Hertel S, Gaipl US et al (2014) The erlangen dose optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results. Strahlenther Onkol 190:293–297
Sedlmayer F, Sautter-Bihl ML, Budach W et al (2013) Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189:825–833
Verstegen NE, Oosterhuis JW, Palma DA et al (2013) Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 24(6):1543–1548
Wenz F et al. (2014) DEGRO practical guidelines for radiotherapy of breast cancer IV: Radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol 190(8):705–714
Einhaltung der ethischen Richtlinien
Interessenkonflikt. F.A. Giordano gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giordano, F., Wenz, F. Fortschritt durch Wissenschaft. Onkologe 20, 1014–1017 (2014). https://doi.org/10.1007/s00761-014-2780-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-014-2780-5